CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating Activities
Net earnings	$ 105,705	$ 131,435
Loss (earnings) from discontinued operations	0	(22,025)
Loss on assets held for sale	(46,946)	0
Adjustments to reconcile net earnings to cash from operating activities:
Depreciation and amortization	67,738	68,625
Share-based compensation expense	8,182	6,745
Other, net	2,363	(5,440)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):
Accounts receivable, net	(42,252)	22,781
Inventories	(73,041)	(63,554)
Prepaid expenses and other assets	(14,921)	(14,778)
Accounts payable	(22,638)	(6,690)
Accrued compensation and employee benefits	(55,559)	(69,554)
Accrued expenses and other liabilities	(16,107)	(36,029)
Accrued and deferred taxes, net	18,108	4,019
Net cash provided by operating activities	24,524	15,535
Investing Activities
Additions to property, plant and equipment	(37,122)	(44,678)
Acquisitions, net of cash and cash equivalents acquired	(175,083)	(68,385)
Proceeds from sale of property, plant, and equipment	170	2,160
Proceeds from sale of businesses	2,245	2,069
Other	(7,900)	(13,763)
Net cash (used in) provided by investing activities	(217,690)	(122,597)
Financing Activities
Repurchase of common stock, including prepayment under an accelerated share repurchase program	0	(44,977)
Change in commercial paper and notes payable	125,893	195,066
Dividends paid to stockholders	(69,809)	(72,691)
Payments to settle employee tax obligations on exercise of share-based awards	(19,608)	(14,943)
Repayments of long-term debt	0	(350,000)
Other	(409)	(1,558)
Net cash used in by financing activities	36,067	(289,103)
Cash Provided by (Used in) Operating Activities, Discontinued Operations	0	19,963
Cash Provided by (Used in) Investing Activities, Discontinued Operations	0	(13,426)
Net Cash Provided by (Used in) Discontinued Operations	0	6,537
Effect of Exchange Rate on Cash and Cash Equivalents	3,892	2,886
Net (decrease) increase in cash and cash equivalents	(153,207)	(386,742)
Cash and cash equivalents at beginning of period	396,221	753,964
Cash and cash equivalents at end of period	$ 243,014	$ 367,222